The stock market has continued to rise. But it's been tricky. Palantir, Robinhood and AMD lead big earnings this week.

Says labor markets remain well-balanced. Says will be exclusive partner of Nubank cards in U.S. Says company’s first agentic transaction occurred in Q3. Says small businesses remain a top priority.

Laura Kirk, Wellington Head of Private Capital Formation and board member of New York Road Runners, says Wellington's private investing arm is a roughly 10-year-old business within a 100-year-old ...

Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Alnylam Pharmaceuticals, Inc. is rated Hold due to high expectations, competitive threats, and revenue expansion. Learn more ...

BofA raised the firm’s price target on Eli Lilly (LLY) to $950 from $900 and keeps a Buy rating on the shares after the company reported “strong” ...

Eli Lilly remains a top GARP opportunity, with Q3 results reinforcing its robust business growth and dominance in incretin ...

Recursion, Roche and Genentech unveiled the latest product of their nearly four-year artificial intelligence drug discovery collaboration. GSK ’s Blenrep was approved by the FDA for treatment of ...

The live event in Nashville, Tenn., featured 60-plus leaders, and also honored several companies with awards for supply chain excellence.

For the Magnificent 7 group, Q3 earnings are expected to be up 11.5% from the same period last year on 15.4% higher revenues, ...

Before being discontinued, the P2X7 receptor blocker had cleared a master protocol study in chronic pain, though Eli Lilly ...

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...